| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.78B | 11.89B | 12.78B | 12.05B | 7.24B | 5.24B |
| Gross Profit | 16.57B | 4.54B | 4.59B | 4.89B | 4.64B | 4.66B |
| EBITDA | -1.03B | 1.80B | 1.65B | 2.39B | 2.17B | 2.35B |
| Net Income | -2.96B | 1.09B | 971.00M | 1.54B | 1.39B | 1.36B |
Balance Sheet | ||||||
| Total Assets | 275.45B | 266.84B | 259.94B | 275.45B | 285.21B | 287.10B |
| Cash, Cash Equivalents and Short-Term Investments | 46.70B | 34.59B | 38.92B | 46.70B | 50.21B | 53.97B |
| Total Debt | 44.95B | 52.60B | 38.25B | 44.95B | 34.12B | 28.10B |
| Total Liabilities | 260.82B | 251.69B | 246.17B | 260.82B | 270.81B | 271.00B |
| Stockholders Equity | 14.62B | 15.15B | 13.77B | 14.62B | 14.41B | 16.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.21B | -3.86B | -1.52B | -3.47B | 10.23B |
| Operating Cash Flow | 0.00 | -8.80B | -3.33B | -1.13B | -2.97B | 10.85B |
| Investing Cash Flow | 0.00 | 2.96B | -4.54B | -2.75B | -198.00M | 3.08B |
| Financing Cash Flow | 0.00 | 5.41B | 285.00M | 19.00M | 277.00M | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £231.98B | 9.62 | 12.07% | 4.27% | -10.53% | 7.24% | |
70 Outperform | £59.08B | 6.14 | 9.46% | 1.50% | 7.44% | 15.64% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £56.23B | 8.87 | 10.75% | 3.41% | -18.98% | 23.57% | |
66 Neutral | £1.37B | 0.87 | 11.68% | ― | 24.32% | 122.52% | |
60 Neutral | £45.38B | 7.35 | 14.55% | 3.85% | 2.05% | 20.10% | |
50 Neutral | ― | ― | ― | 5.85% | ― | ― |